| No. |
Name Length
|
Chromosome No./Scaffold Id Scaffold Length |
BLAST (vs nr) |
Gene ontology |
Transcript Level |
| 2311 |
A_BomoFB_comp10442_c2_seq10
1240bp |
|
presenilin_enhancer_[Bombyx_mori] |
| GO:0005770 |
C |
late endosome |
| GO:0005886 |
C |
plasma membrane |
| GO:0007219 |
P |
Notch signaling pathway |
| GO:0007220 |
P |
Notch receptor processing |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0055037 |
C |
recycling endosome |
| GO:0070765 |
C |
gamma-secretase complex |
|
FPKM:5.09 TPM:5.57 |
| 2312 |
A_BomoFB_comp10442_c2_seq11
245bp |
|
|
|
FPKM:0.05 TPM:0.06 |
| 2313 |
A_BomoFB_comp10442_c2_seq12
1791bp |
|
PREDICTED:_probable_tRNA_(uracil-O(2)-)-methyltransferase,_partial_[Bombyx_mori] |
|
FPKM:0.00 TPM:0.00 |
| 2314 |
A_BomoFB_comp10442_c2_seq13
3516bp |
|
PREDICTED:_growth/differentiation_factor_8_[Bombyx_mori] |
| GO:0005125 |
F |
cytokine activity |
| GO:0005576 |
C |
extracellular region |
| GO:0005615 |
C |
extracellular space |
| GO:0008083 |
F |
growth factor activity |
| GO:0008201 |
F |
heparin binding |
| GO:0040007 |
P |
growth |
|
FPKM:1.87 TPM:2.05 |
| 2315 |
A_BomoFB_comp10442_c2_seq14
3714bp |
|
PREDICTED:_growth/differentiation_factor_8_[Bombyx_mori] |
| GO:0005125 |
F |
cytokine activity |
| GO:0005576 |
C |
extracellular region |
| GO:0005615 |
C |
extracellular space |
| GO:0008083 |
F |
growth factor activity |
| GO:0008201 |
F |
heparin binding |
| GO:0040007 |
P |
growth |
|
FPKM:0.01 TPM:0.01 |
| 2316 |
A_BomoFB_comp10442_c2_seq15
211bp |
|
|
|
FPKM:1.43 TPM:1.57 |
| 2317 |
A_BomoFB_comp10442_c2_seq16
2012bp |
|
PREDICTED:_isocitrate_dehydrogenase_[NAD]_subunit_beta,_mitochondrial_[Bombyx_mori] |
| GO:0000287 |
F |
magnesium ion binding |
| GO:0004449 |
F |
isocitrate dehydrogenase (NAD+) activity |
| GO:0005739 |
C |
mitochondrion |
| GO:0006099 |
P |
tricarboxylic acid cycle |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016616 |
F |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO:0046872 |
F |
metal ion binding |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
FPKM:0.00 TPM:0.00 |
| 2318 |
A_BomoFB_comp10442_c2_seq17
3162bp |
|
PREDICTED:_growth/differentiation_factor_8_[Bombyx_mori] |
| GO:0005125 |
F |
cytokine activity |
| GO:0005576 |
C |
extracellular region |
| GO:0005615 |
C |
extracellular space |
| GO:0008083 |
F |
growth factor activity |
| GO:0008201 |
F |
heparin binding |
| GO:0040007 |
P |
growth |
|
FPKM:8.18 TPM:8.96 |
| 2319 |
A_BomoFB_comp10442_c2_seq18
3094bp |
|
PREDICTED:_growth/differentiation_factor_8_[Bombyx_mori] |
| GO:0005125 |
F |
cytokine activity |
| GO:0005576 |
C |
extracellular region |
| GO:0005615 |
C |
extracellular space |
| GO:0008083 |
F |
growth factor activity |
| GO:0008201 |
F |
heparin binding |
| GO:0040007 |
P |
growth |
|
FPKM:1.47 TPM:1.61 |
| 2320 |
A_BomoFB_comp10442_c2_seq19
1392bp |
|
PREDICTED:_isocitrate_dehydrogenase_[NAD]_subunit_beta,_mitochondrial_[Bombyx_mori] |
| GO:0000287 |
F |
magnesium ion binding |
| GO:0004449 |
F |
isocitrate dehydrogenase (NAD+) activity |
| GO:0005739 |
C |
mitochondrion |
| GO:0006099 |
P |
tricarboxylic acid cycle |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016616 |
F |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO:0046872 |
F |
metal ion binding |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
FPKM:12.13 TPM:13.29 |
| 2321 |
A_BomoFB_comp10442_c2_seq2
3319bp |
|
PREDICTED:_growth/differentiation_factor_8_[Bombyx_mori] |
| GO:0005125 |
F |
cytokine activity |
| GO:0005576 |
C |
extracellular region |
| GO:0005615 |
C |
extracellular space |
| GO:0008083 |
F |
growth factor activity |
| GO:0008201 |
F |
heparin binding |
| GO:0040007 |
P |
growth |
|
FPKM:0.00 TPM:0.00 |
| 2322 |
A_BomoFB_comp10442_c2_seq20
3499bp |
|
PREDICTED:_growth/differentiation_factor_8_[Bombyx_mori] |
| GO:0005125 |
F |
cytokine activity |
| GO:0005576 |
C |
extracellular region |
| GO:0005615 |
C |
extracellular space |
| GO:0008083 |
F |
growth factor activity |
| GO:0008201 |
F |
heparin binding |
| GO:0040007 |
P |
growth |
|
FPKM:0.02 TPM:0.02 |
| 2323 |
A_BomoFB_comp10442_c2_seq21
2039bp |
|
PREDICTED:_isocitrate_dehydrogenase_[NAD]_subunit_beta,_mitochondrial_[Bombyx_mori] |
| GO:0000287 |
F |
magnesium ion binding |
| GO:0004449 |
F |
isocitrate dehydrogenase (NAD+) activity |
| GO:0005739 |
C |
mitochondrion |
| GO:0006099 |
P |
tricarboxylic acid cycle |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016616 |
F |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO:0046872 |
F |
metal ion binding |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
FPKM:0.00 TPM:0.00 |
| 2324 |
A_BomoFB_comp10442_c2_seq22
1543bp |
|
PREDICTED:_isocitrate_dehydrogenase_[NAD]_subunit_beta,_mitochondrial_[Bombyx_mori] |
| GO:0000287 |
F |
magnesium ion binding |
| GO:0004449 |
F |
isocitrate dehydrogenase (NAD+) activity |
| GO:0005739 |
C |
mitochondrion |
| GO:0006099 |
P |
tricarboxylic acid cycle |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016616 |
F |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO:0046872 |
F |
metal ion binding |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
FPKM:5.58 TPM:6.11 |
| 2325 |
A_BomoFB_comp10442_c2_seq23
709bp |
|
PREDICTED:_LOW_QUALITY_PROTEIN:_protein_HIRA_homolog_[Papilio_machaon] |
|
FPKM:0.00 TPM:0.00 |
| 2326 |
A_BomoFB_comp10442_c2_seq24
1841bp |
|
PREDICTED:_isocitrate_dehydrogenase_[NAD]_subunit_beta,_mitochondrial_[Bombyx_mori] |
| GO:0000287 |
F |
magnesium ion binding |
| GO:0004449 |
F |
isocitrate dehydrogenase (NAD+) activity |
| GO:0005739 |
C |
mitochondrion |
| GO:0006099 |
P |
tricarboxylic acid cycle |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016616 |
F |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO:0046872 |
F |
metal ion binding |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
FPKM:5.15 TPM:5.64 |
| 2327 |
A_BomoFB_comp10442_c2_seq25
3377bp |
|
PREDICTED:_growth/differentiation_factor_8_[Bombyx_mori] |
| GO:0005125 |
F |
cytokine activity |
| GO:0005576 |
C |
extracellular region |
| GO:0005615 |
C |
extracellular space |
| GO:0008083 |
F |
growth factor activity |
| GO:0008201 |
F |
heparin binding |
| GO:0040007 |
P |
growth |
|
FPKM:2.52 TPM:2.76 |
| 2328 |
A_BomoFB_comp10442_c2_seq26
2879bp |
|
PREDICTED:_growth/differentiation_factor_8_[Bombyx_mori] |
| GO:0005125 |
F |
cytokine activity |
| GO:0005576 |
C |
extracellular region |
| GO:0005615 |
C |
extracellular space |
| GO:0008083 |
F |
growth factor activity |
| GO:0008201 |
F |
heparin binding |
| GO:0040007 |
P |
growth |
|
FPKM:2.17 TPM:2.38 |
| 2329 |
A_BomoFB_comp10442_c2_seq27
1611bp |
|
|
|
FPKM:0.00 TPM:0.00 |
| 2330 |
A_BomoFB_comp10442_c2_seq28
625bp |
|
|
|
FPKM:0.49 TPM:0.53 |
| 2331 |
A_BomoFB_comp10442_c2_seq29
1814bp |
|
PREDICTED:_isocitrate_dehydrogenase_[NAD]_subunit_beta,_mitochondrial_[Bombyx_mori] |
| GO:0000287 |
F |
magnesium ion binding |
| GO:0004449 |
F |
isocitrate dehydrogenase (NAD+) activity |
| GO:0005739 |
C |
mitochondrion |
| GO:0006099 |
P |
tricarboxylic acid cycle |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016616 |
F |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO:0046872 |
F |
metal ion binding |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
FPKM:3.20 TPM:3.50 |
| 2332 |
A_BomoFB_comp10442_c2_seq3
1419bp |
|
PREDICTED:_isocitrate_dehydrogenase_[NAD]_subunit_beta,_mitochondrial_[Bombyx_mori] |
| GO:0000287 |
F |
magnesium ion binding |
| GO:0004449 |
F |
isocitrate dehydrogenase (NAD+) activity |
| GO:0005739 |
C |
mitochondrion |
| GO:0006099 |
P |
tricarboxylic acid cycle |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016616 |
F |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO:0046872 |
F |
metal ion binding |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
FPKM:8.79 TPM:9.63 |
| 2333 |
A_BomoFB_comp10442_c2_seq30
287bp |
|
|
|
FPKM:0.00 TPM:0.00 |
| 2334 |
A_BomoFB_comp10442_c2_seq31
1832bp |
|
PREDICTED:_isocitrate_dehydrogenase_[NAD]_subunit_beta,_mitochondrial_[Bombyx_mori] |
| GO:0000287 |
F |
magnesium ion binding |
| GO:0004449 |
F |
isocitrate dehydrogenase (NAD+) activity |
| GO:0005739 |
C |
mitochondrion |
| GO:0006099 |
P |
tricarboxylic acid cycle |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016616 |
F |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO:0046872 |
F |
metal ion binding |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
FPKM:0.00 TPM:0.00 |
| 2335 |
A_BomoFB_comp10442_c2_seq32
3534bp |
|
PREDICTED:_growth/differentiation_factor_8_[Bombyx_mori] |
| GO:0005125 |
F |
cytokine activity |
| GO:0005576 |
C |
extracellular region |
| GO:0005615 |
C |
extracellular space |
| GO:0008083 |
F |
growth factor activity |
| GO:0008201 |
F |
heparin binding |
| GO:0040007 |
P |
growth |
|
FPKM:0.00 TPM:0.00 |
| 2336 |
A_BomoFB_comp10442_c2_seq33
570bp |
|
PREDICTED:_probable_tRNA_(uracil-O(2)-)-methyltransferase,_partial_[Bombyx_mori] |
|
FPKM:0.00 TPM:0.00 |
| 2337 |
A_BomoFB_comp10442_c2_seq34
409bp |
|
|
|
FPKM:0.00 TPM:0.00 |
| 2338 |
A_BomoFB_comp10442_c2_seq4
1427bp |
|
PREDICTED:_gelsolin-like_[Amyelois_transitella] |
| GO:0003779 |
F |
actin binding |
| GO:0005509 |
F |
calcium ion binding |
| GO:0005576 |
C |
extracellular region |
| GO:0005737 |
C |
cytoplasm |
| GO:0005829 |
C |
cytosol |
| GO:0005856 |
C |
cytoskeleton |
| GO:0005884 |
C |
actin filament |
| GO:0006909 |
P |
phagocytosis |
| GO:0030041 |
P |
actin filament polymerization |
| GO:0045010 |
P |
actin nucleation |
| GO:0046872 |
F |
metal ion binding |
| GO:0051014 |
P |
actin filament severing |
| GO:0051016 |
P |
barbed-end actin filament capping |
|
FPKM:50.32 TPM:55.14 |
| 2339 |
A_BomoFB_comp10442_c2_seq5
1570bp |
|
PREDICTED:_isocitrate_dehydrogenase_[NAD]_subunit_beta,_mitochondrial_[Bombyx_mori] |
| GO:0000287 |
F |
magnesium ion binding |
| GO:0004449 |
F |
isocitrate dehydrogenase (NAD+) activity |
| GO:0005739 |
C |
mitochondrion |
| GO:0006099 |
P |
tricarboxylic acid cycle |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016616 |
F |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO:0046872 |
F |
metal ion binding |
| GO:0051287 |
F |
NAD binding |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
FPKM:4.58 TPM:5.02 |
| 2340 |
A_BomoFB_comp10442_c2_seq6
3301bp |
|
PREDICTED:_growth/differentiation_factor_8_[Bombyx_mori] |
| GO:0005125 |
F |
cytokine activity |
| GO:0005576 |
C |
extracellular region |
| GO:0005615 |
C |
extracellular space |
| GO:0008083 |
F |
growth factor activity |
| GO:0008201 |
F |
heparin binding |
| GO:0040007 |
P |
growth |
|
FPKM:5.78 TPM:6.33 |